Skip to main content
OpenTrials

Clinical trial condition

Hemoglobin SC Disease

Explore clinical trials studying Hemoglobin SC Disease. Study availability and eligibility vary by location and protocol.

20 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Hemoglobin SC Disease trial results

Completed

Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC)

NCT03264989

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
Locations
  • Novartis Investigative Site Orange, Florida, United States
  • Novartis Investigative Site Tampa, Florida, United States
  • Childrens Healthcare of Atlanta . Atlanta, Georgia, United States
  • Augusta University Georgia Patient Treatment Augusta, Georgia, United States
View Trial Details
Completed

Safety Study of MP4CO in Adult Sickle Cell Patients

NCT01356485

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +12 more
Locations
  • Hôpital Henri Mondor Créteil, France
  • Sickle Cell Unit, University of West Indies Kingston, Jamaica
  • Rafic Hariri University Hospital Beirut, Lebanon
  • Guy's Hospital London, United Kingdom
View Trial Details
Completed

Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies

NCT00153985

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +11 more
Locations
  • Winship Cancer Institute-Emory University Atlanta, Georgia, United States
  • Feist-Weiller Cancer Center-LSU Shreveport, Louisiana, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions